Bluesight, the leading provider of Medication Intelligence™ solutions for health systems and hospital pharmacies, announced the acquisition of Sectyr, a top-tier compliance and audit management platform. This acquisition expands Bluesight’s portfolio to include robust 340B audit and compliance tools in response to growing demand from its customers. Sectyr is recognized for its industry-leading solutions designed to simplify and streamline regulatory compliance and auditing, specifically in the 340B Drug Pricing Program. With the addition of Sectyr’s tools, Bluesight continues its mission of empowering healthcare organizations to ensure medication safety, compliance, and operational efficiency.
Read the full article: Bluesight Expands Capabilities through Acquisition of Sectyr //
Source: https://www.prnewswire.com/news-releases/bluesight-expands-capabilities-through-acquisition-of-sectyr-302278582.html